🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of this study was to compare the efficacy and safety of the c...
Status
Completed
Location
Site JP00024
Start Date
2016-11-02
Trial ID
NCT02918968
Treatments Being Tested
The main purpose of this study is to learn more about the safety and tolera...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2024-01-12
Trial ID
NCT05999968
Treatments Being Tested
This study will evaluate if adding the investigational drug Dovitinib to st...
Status
Withdrawn
Location
Comprehensive Cancer Centers of Nevada
Start Date
TBD
Trial ID
NCT02065323
Treatments Being Tested
The purpose of this study was to evaluate the efficacy of enzalutamide plus...
Status
Completed
Location
Site US10016
Start Date
2016-03-09
Trial ID
NCT02677896
Treatments Being Tested
The purpose of this study is to investigate if androgen deprivation therapy...
Status
Completed
Location
Herlev Hospital
Start Date
2014-04
Trial ID
NCT02102646
Treatments Being Tested
This multicenter, prospective, cohort study enrolled patients with metastat...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-15
Trial ID
NCT06134271
Treatments Being Tested
The purpose of this study was to evaluate the safety and tolerability of en...
Status
Completed
Location
Site IN00002
Start Date
2018-09-19
Trial ID
NCT03641560
Treatments Being Tested
The goal of this clinical research study is to learn if treatment with stan...
Status
Completed
Location
UCSF University of California
Start Date
2013-03-18
Trial ID
NCT01751438
The purpose of this study was to evaluate the efficacy and safety of enzalu...
Status
Active Not Recruiting
Location
Site CN86022
Start Date
2019-09-11
Trial ID
NCT04076059
Treatments Being Tested
STAMPEDE2 is a clinical trial comparing two new treatments with standard of...
Status
Recruiting
Location
Mount Vernon Hospital
Start Date
2024-06-11
Trial ID
NCT06320067